Clinical outcomes modelling

Clinical outcomes modelling

Current focus

We develop and validate predictive models of treatment response and normal tissue toxicity in patients treated with proton therapy. By integrating dosimetric data, quantitative imaging biomarkers, and clinical follow-up, we aim to understand the biological mechanisms underlying treatment outcomes and support therapeutic decisions. Current work focuses on statistical modelling of treatment response, integrating radiomic feature extraction, habitat imaging, and mixed-effects models applied to longitudinal patient data for both tumour response and normal tissue complications.

NTCP modelling Survival analysis Radiomics Habitat imaging Mixed-effects models
View projects & publications →